Seeking an investor with pharma experience for a WHO-GMP-certified manufacturing unit in Mathura.

- Contract manufacturer of antibiotic tablets, capsules, and syrups.
- We have a huge capacity to manufacture the Potassium Clavulanate section and last year's turnover was INR 7 crore.
- We can do more than INR 25 crore turnover but looking for working capital and some investments.
- Production capacity (daily):
• 20 lakh tablets.
• 20,000 dry syrups.
• 5 lakh capsules.
- The plant has 50 regular employees and about 50 contract workers.
- The investor gets a 50% share in this unit. This means they get a 50% share of all the assets in this unit.
- We as a group have 5 other units and have registered this specific unit as a separate legal entity.

We are a contract manufacturer for more than 200 marketing companies. We manufacture:
- WHO-GMP beta-lactam tablets.
- Capsules.
- Dry syrups.
- Other medicines.
Our top-selling products are antibiotics like beta-lactam tablets.

From Canara Bank, we have a term loan of INR 1.5 crore, an OD of INR 1 crore, and some creditors which are our suppliers. This unit is registered as a proprietorship.

Tangible assets: - 1,000 sq. m. of land worth INR 25,000 per sq. m. (99-year leasehold that can easily be converted into freehold) - Plant, machinery, and fixtures worth INR 4 crore. Intangible assets: - WHO-GMP certification.